AHMA vs BABA

AHMA exhibits a strong Piotroski F-Score of 7/9, indicating solid operational health and improving profitability, but lacks an Altman Z-Score, which raises concern about financial distress risk. The stock trades at a steep valuation with a P/E of 129.50—far above the sector average of 43.00—despite modest revenue growth and a recent 190.9% earnings surge that may be unsustainable. The Graham Number of $0.46 and intrinsic value of $1.18 suggest deep undervaluation, yet the current price of $5.18 reflects a premium driven by speculative growth expectations. Technical trends are bearish, and insider sentiment is neutral, with no dividend history. Overall, the stock appears overvalued relative to fundamentals and carries high risk despite strong profitability metrics.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.